Gefitinib-trastuzumab combination on hormone-refractory prostate cancer xenograft. [electronic resource]
Producer: 20050816Description: 1467-73 p. digitalISSN:- 0959-8049
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Cell Division -- drug effects
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Gefitinib
- Humans
- Male
- Mice
- Mice, Nude
- Prostatic Neoplasms -- blood supply
- Quinazolines -- administration & dosage
- Trastuzumab
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.